SIGNAVENT Trademark

Trademark Overview


On Monday, August 29, 2016, a trademark application was filed for SIGNAVENT with the United States Patent and Trademark Office. The USPTO has given the SIGNAVENT trademark a serial number of 87153937. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Thursday, January 18, 2018. This trademark is owned by Pfizer Inc.. The SIGNAVENT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
signavent

General Information


Serial Number87153937
Word MarkSIGNAVENT
Filing DateMonday, August 29, 2016
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateThursday, January 18, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 17, 2017

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateThursday, January 18, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Thursday, January 18, 2018ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
Thursday, January 18, 2018ABANDONMENT - AFTER PUBLICATION
Wednesday, January 17, 2018TEAS EXPRESS ABANDONMENT RECEIVED
Saturday, July 22, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 20, 2017EXTENSION 1 GRANTED
Thursday, July 20, 2017EXTENSION 1 FILED
Thursday, July 20, 2017TEAS EXTENSION RECEIVED
Tuesday, March 14, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 17, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 17, 2017PUBLISHED FOR OPPOSITION
Wednesday, December 28, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, December 9, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 7, 2016ASSIGNED TO EXAMINER
Friday, September 2, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 1, 2016NEW APPLICATION ENTERED IN TRAM